Statin can reduce the risk of hepatocellular carcinoma among patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis : European Journal of Gastroenterology & Hepatology

Secondary Logo

Journal Logo

Review

Statin can reduce the risk of hepatocellular carcinoma among patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis

Zhang, Jiea,b; Fu, Shifenga,b; Liu, Delianga,b; Wang, Yongjuna,b; Tan, Yuyonga,b

Author Information
European Journal of Gastroenterology & Hepatology 35(4):p 353-358, April 2023. | DOI: 10.1097/MEG.0000000000002517

Abstract

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid